ProductLife Group at Pharma Microbiology Congress 2025

ProductLife Group is among the sponsors of the Pharma Microbiology Congress 2025, organized by Pharma Education Center. Recognized as one of Europe’s most important conferences on sterile manufacturing, the event serves as a leading platform for sharing knowledge, exploring innovation, and addressing the challenges shaping the future of pharmaceutical microbiology.

The Congress will be held in a dual format, with a virtual edition on 21–22 October 2025 (9:00–17:30 CET) and the in-person edition on 28–29 October 2025 at Palazzo degli Affari in Florence. Alongside presentations and debates, the programme will also include interactive workshops, networking opportunities, and a welcome cocktail evening.

With its 12 thematic sessions, 12 round tables, 30 technical speeches, 8 webinars, and a Lectio Magistralis, the 2025 edition promises a comprehensive agenda and an engaging forum for professionals across the pharmaceutical industry. Discussions will explore the evolution of sterile manufacturing and aseptic processes, new approaches to contamination control, the role of rapid microbiological methods, and the contribution of digital technologies in laboratory settings. A strong focus will also be placed on regulatory updates, offering participants valuable insights into compliance trends and expectations in an increasingly complex landscape.

This year, Barbara Scolaro, System Integration & Testing Senior Engineer at C&P Engineering (a ProductLife Group company), will join the speaker line-up. Her presentation, “Smart Lab: Transforming Microbiology through Digital Innovation”, will be part of the session dedicated to revolutionizing sterile manufacturing and controls through digital transformation. 

Barbara will highlight how digitalization is redefining microbiology laboratories, from real-time monitoring and enhanced traceability to improved data integrity and compliance. Her contribution will underline how these advancements not only boost operational efficiency, but also foster a proactive quality culture—an essential step in supporting pharmaceutical companies as they adapt to a more demanding regulatory and technological environment. 

By bringing her expertise to the Congress, Barbara reflects PLG’s commitment to bridging scientific knowledge and digital innovation, ensuring clients benefit from smarter processes and reliable solutions throughout the product lifecycle. 

The Pharma Microbiology Congress 2025 is a unique occasion to connect with regulators, experts, and peers, discover innovative technologies, and gain practical insights into the future of pharmaceutical microbiology.  

In addition to Barbara, PLG colleagues Andrea Pieri, Marco Torciani, Silvio Mastrominico and Giuseppe Latella are attending the Florence edition, ready to engage with participants, exchange perspectives, and explore new opportunities for collaboration.